[1] KLARESKOG L,CATRINA A I,PAGET S.Rheumatoid arthritis[J].Lancet,2009,373(9664):659-672.
[2] ARNETT F C,EDWORTHYET S M,BLOCH D A,et al.The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis[J].Arthritis Rheum,1988,31(3):315-324.
[3] NEUMANN E,LEFEVRE S,ZIMMERMANN B,et al.Rheumatoid arthritis progression mediated by activated synovial fibroblasts[J].Trends Mol Med,2010,16(10):458-468.
[4] OKADA Y,EYRE S,SUZUKI A,et al.Genetics of rheumatoid arthritis 2018 status[J].Ann Rheum Dis,2019,78(4):446-453.
[5] OKADA Y,WU D,TRYNKA G,et al.Genetics of rheumatoid arthritis contributes to biology and drug discovery[J].Nature,2014,506(7488):376-381.
[6] FILER A.The fibroblast as a therapeutic target in rheumatoid arthritis[J].Curr Opin Pharmacol,2013,13(3):413-419.
[7] SCHUBELER D.Function and information content of DNA methylation[J].Nature,2015,517(7534):321-326.
[8] JIN B,LI Y,ROBERTSON K D.DNA methylation:superior or subordinate in the epigenetic hierarchy?[J].Genes Cancer,2011,2(6):607-617.
[9] NAKANO K,WHITAKER J W,BOYLE D L,et al.DNA methylome signature in rheumatoid arthritis[J].Ann Rheum Dis,2013,72(1):110-117.
[10] KAROUZAKIS E,TRENKMANN M,GAY R E,et al.Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts[J].Immunol,2014,193(10):4945-4951.
[11] PARK S H,KIM S K,CHOE J Y,et al.Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis[J].Mol Cells,2013,35(4):298-304.
[12] RHEAD B,HOLINGUE C,CLOE M,et al.Rheumatoid arthritis naive T cells share hypermethylation sites with synoviocytes[J].Arthritis Rheumatol,2017,69(3):550-559.
[13] KAROUZAKIS E,RAZA K,KOLLING C,et al.Analysis of early changes in DNA methylation in synovial fibroblasts of RA patients before diagnosis[J] Sci Rep,2018,8(1):7370.
[14] AI R,WHITAKER J,BOYLE D,et al.DNA methylome signature in synoviocytes from patients with early rheumatoid arthritis compared to synoviocytes from patients with longstanding rheumatoid arthritis[J].Arthritis Rheumatol,2015,67(7):1978-1980.
[15] FIRESTEIN G S.Pathogenesis of rheumatoid arthritis:the intersection of genetics and epigenetics[J].Trans Am Clin Climatol Assoc,2018,129:171-182.
[16] ARAKI Y,TSUZUKI T,AIZAKI Y,et al.Histone methylation and STAT-3 differentially regulate interleukin-6-induced matrix metalloproteinase gene activation in rheumatoid arthritis synovial fibroblast[J].Arthritis Rheumatol,2016,68(5):1111-1123.
[17] AI R,LARAGIONE T,HAMMAKER D,et al.Comprehensive epigenetic landscape of rheumatoid arthritis fibroblast-like synoviocytes[J].Nat Commun,2018,9(1):1921.
[18] NYGAARD G,GARY S,FIRESTEIN J.Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes[J].Nat Rev Rheumatol,2020,16(6):316-333.
[19] DONG X,WENG Z.The correlation between histone modifications and gene expression[J].Epigenomics,2013,5(2):113-116.
[20] NICODEME E,JEFFREY K,SCHAEFER U,et al.Suppression of inflammation by a synthetic histone mimic[J].Nature,2010,468(7327):1119-1123.
[21] LEE A,QIAO Y,GRIGORIEV G,et al.Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts[J].Arthritis Rheum,2013,65(4):928-938.
[22] SOHN C,LEE A,QIAO Y,et al.Prolonged tumor necrosis factor αprimes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin[J].Arthritis Rheumatol,2015,67(1):86-95.
[23] KAWABATA T,NISHIDA K,TAKASUGI K,et al.Increased activity and expression of histone deacetylase 1 in relation to tumor necrosis factor-α in synovial tissue of rheumatoid arthritis[J].Arthritis Res Ther,2010,12(4):R133.
[24] ANGIOLILLI C,GRABIEC A,FERGUSON B,et al.Inflammatory cytokines epigenetically regulate rheumatoid arthritis fibroblast-like synoviocyte activation by suppressing HDAC5 expression[J].Ann Rheum Dis,2016,75(2):430-438.
[25] NAKAMACHI Y,KAWANO S,TAKENOKUCHI M,et al.MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis[J].Arthritis Rheum,2009,60(5):1294-1304.
[26] HAMMOND S M.An overview of microRNAs[J].Adv Drug Deliv Rev,2015,87:3-14.
[27] NIEDERER F,TRENKMANN M,OSPELT C,et al.Down-regulation of microRNA-34a* in rheumatoid arthritis synovial fibroblasts promotes apoptosis resistance[J].Arthritis Rheum,2012,64(6):1771-1779.
[28] STANCZYK J,OSPELT C,KAROUZAKIS E,et al.Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation[J].Arthritis Rheum,2011,63(2):373-381.
[29] ZHAO F,DONG J,GUO J L,et al.Inhibiting role of long non-coding RNA LINC01197 in inflammation in rheumatoid arthritis through the microRNA-150/THBS2 axis[J].Exp Cell Res,2020,394(2):112-136.
[30] PIAO X M,ZHOU J R,HU J D.Role of RP11-83J16.1,a novel long non-coding RNA,in rheumatoid arthritis[J].Am J Transl Res,2020,12(4):1397-1414.
[31] CAI Y J,LIANG R G,XIAO S B,et al.Circ_0088194 promotes the invasion and migration of rheumatoid arthritis fibroblast-like synoviocytes via the miR-766-3p/MMP2 axis[J].Frontiers in Immunology,2021,12:628-654.
[32] HAMMAKER D,FIRESTEIN G S.Epigenetics of inflammatory arthritis[J].Curr Opin Rheumatol,2018,30(2):188-196.
[33] LI M,LIU X,SUN X,et al.Therapeutic effects of NK-HDAC-1,a novel histone deacetylase inhibitor,on collagen-induced arthritis through the induction of apoptosis of fibroblast-like synoviocytes[J].Inflammation,2013,36(4):888-896.
[34] ANGIOLILLI C,KABALA P,GRABIEC A,et al.Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes:beyond transcriptional regulation[J].Arthritis Res Ther,2018,20(1):148.
[35] GRABIEC A M,KORCHYNSKYI O,TAK P P,et al.Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay[J].Ann Rheum Dis,2012,71(3):424-431.
[36] WU W,QIN M,JIA W,et al.Cystathionine-gamma-lyase ameliorates the histone demethylase JMJD3-mediated autoimmune response in rheumatoid arthritis[J].Cell Mol Immunol,2019,16(8):694-705.
[37] KLEIN K,KABALA P,GRABIEC A,et al.The bromodomain protein inhibitor I-BET151 suppresses expression of inflammatory genes and matrix degrading enzymes in rheumatoid arthritis synovial fibroblasts[J].Ann Rheum Dis,2016,75(2):422-429.
[38] XIAO Y,LIANG L,HUANG M,et al.Bromodomain and extra-terminal domain bromodomain inhibition prevents synovial inflammation via blocking IκB kinase-dependent NF-κB activation in rheumatoid fibroblast-like synoviocytes[J].Rheumatology,2016,55(1):173-184.
[39] MELE D A,SALMERON A,GHOSH S,et al.BET bromodomain inhibition suppresses TH17-mediated pathology[J].J Exp Med,2013,210(11):2181-2190.
[40] TOUGH D F,TAK P P,TARAKHOVSKY A,et al.Epigenetic drug discovery:breaking through the immune barrier[J].Nat Rev Drug Discov,2016,15(12):835-853.
[41] SUBRAMANIAM D,THOMBRE R,DHAR A,et al.DNA methyltransferases:a novel target for prevention and therapy[J].Front Oncol,2014,4:80. |
